| 1. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB et al.. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.. Nature, 450 (7170): (712-6). [PMID:18046409] [10.1021/op500134e] |
| 2. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ et al.. (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.. Science, 317 (5837): (516-9). [PMID:17588900] [10.1021/op500134e] |
| 3. Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano PS, Huber LJ. (2006) Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage.. Mol Cell Biol, 26 (1): (28-38). [PMID:16354677] [10.1021/op500134e] |
| 4. Pasco MY, Rotili D, Altucci L, Farina F, Rouleau GA, Mai A, Néri C. (2010) Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues.. J Med Chem, 53 (3): (1407-11). [PMID:20041717] [10.1021/op500134e] |
| 5. Maurer B, Rumpf T, Scharfe M, Stolfa DA, Schmitt ML, He W, Verdin E, Sippl W, Jung M. (2012) Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.. ACS Med Chem Lett, 3 (12): (1050-3). [PMID:24900427] [10.1021/op500134e] |
| 6. Cai X, Zhai HX, Wang J, Forrester J, Qu H, Yin L, Lai CJ, Bao R, Qian C. (2010) Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer.. J Med Chem, 53 (5): (2000-9). [PMID:20143778] [10.1021/op500134e] |
| 7. Migliore M, Habrant D, Sasso O, Albani C, Bertozzi SM, Armirotti A, Piomelli D, Scarpelli R. (2016) Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.. Eur J Med Chem, 109 (13): (216-37). [PMID:26774927] [10.1021/op500134e] |
| 8. Ai T, Wilson DJ, More SS, Xie J, Chen L. (2016) 5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.. J Med Chem, 59 (7): (2928-41). [PMID:26982234] [10.1021/op500134e] |
| 9. Nayagam VM, Wang X, Tan YC, Poulsen A, Goh KC, Ng T, Wang H, Song HY, Ni B, Entzeroth M et al.. (2006) SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents.. J Biomol Screen, 11 (8): (959-67). [PMID:17099246] [10.1021/op500134e] |
| 10. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.. EMBO J, 23 (12): (2369-80). [PMID:15152190] [10.1021/op500134e] |
| 11. Antonello Mai,Sergio Valente,Sarah Meade,Vincenzo Carafa,Maria Tardugno,Angela Nebbioso,Andrea Galmozzi,Nico Mitro,Emma De Fabiani,Lucia Altucci,Aleksey Kazantsev. (2009-08-12) Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.. Journal of medicinal chemistry, 52 ((17)): (5496-5504). [PMID:19663498] |
| 12. Takayoshi Suzuki,Tomomi Asaba,Erika Imai,Hiroki Tsumoto,Hidehiko Nakagawa,Naoki Miyata. (2009-08-25) Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.. Bioorganic & medicinal chemistry letters, 19 ((19)): (5670-5672). [PMID:19700324] |
| 13. Jamin D Steffen,Donna L Coyle,Komath Damodaran,Paul Beroza,Myron K Jacobson. (2011-06-23) Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG).. Journal of medicinal chemistry, 54 ((15)): (5403-5413). [PMID:21692479] |
| 14. Yi-Pei Chen,Chad C Catbagan,Jeannette T Bowler,Trevor Gokey,Natalie D M Goodwin,Anton B Guliaev,Weiming Wu,Taro Amagata. (2013-11-26) Evaluation of benzoic acid derivatives as sirtuin inhibitors.. Bioorganic & medicinal chemistry letters, 24 ((1)): (349-352). [PMID:24269123] |
| 15. In Hye Lee,Liu Cao,Raul Mostoslavsky,David B Lombard,Jie Liu,Nicholas E Bruns,Maria Tsokos,Frederick W Alt,Toren Finkel. (2008-02-26) A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy.. Proceedings of the National Academy of Sciences of the United States of America, 105 ((9)): (3374-3379). [PMID:18296641] |
| 16. Sharon Gauci,Andreas O Helbig,Monique Slijper,Jeroen Krijgsveld,Albert J R Heck,Shabaz Mohammed. (2009-05-06) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.. Analytical chemistry, 81 ((11)): (4493-4501). [PMID:19413330] |
| 17. Brandi D Sanders,Brittany Jackson,Michael Brent,Alexander M Taylor,Weiwei Dang,Shelley L Berger,Stuart L Schreiber,Konrad Howitz,Ronen Marmorstein. (2009-09-08) Identification and characterization of novel sirtuin inhibitor scaffolds.. Bioorganic & medicinal chemistry, 17 ((19)): (7031-7041). [PMID:19734050] |
| 18. Taki Sakai,Yotaro Matsumoto,Minoru Ishikawa,Kazuyuki Sugita,Yuichi Hashimoto,Nobuhiko Wakai,Akio Kitao,Era Morishita,Chikashi Toyoshima,Tomoatsu Hayashi,Tetsu Akiyama. (2014-12-18) Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.. Bioorganic & medicinal chemistry, 23 ((2)): (328-339). [PMID:25515955] |
| 19. Mai A, Cheng D, Bedford MT, Valente S, Nebbioso A, Perrone A, Brosch G, Sbardella G, De Bellis F, Miceli M, Altucci L.. (2008) epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.. J Med Chem, 51 (7): (2279-2290). [PMID:18348515] [10.1021/jm701595q] |
| 20. Vu CB, Bemis JE, Disch JS, Ng PY, Nunes JJ, Milne JC, Carney DP, Lynch AV, Smith JJ, Lavu S, Lambert PD, Gagne DJ, Jirousek MR, Schenk S, Olefsky JM, Perni RB.. (2009) Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.. J Med Chem, 52 (5): (1275-1283). [PMID:19199480] [10.1021/jm8012954] |
| 21. Medda F, Russell RJ, Higgins M, McCarthy AR, Campbell J, Slawin AM, Lane DP, Lain S, Westwood NJ.. (2009) Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.. J Med Chem, 52 (9): (2673-2682). [PMID:19419202] [10.1021/jm8014298] |
| 22. Rotili D, Carafa V, Tarantino D, Botta G, Nebbioso A, Altucci L, Mai A.. (2011) Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.. Bioorg Med Chem, 19 (12): (3659-3668). [PMID:21306905] [10.1016/j.bmc.2011.01.025] |
| 23. Huber K, Superti-Furga G.. (2011) After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.. Bioorg Med Chem, 19 (12): (3616-3624). [PMID:21306906] [10.1016/j.bmc.2011.01.018] |
| 24. Hirsch BM, Hao Y, Li X, Wesdemiotis C, Wang Z, Zheng W.. (2011) A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK).. Bioorg Med Chem Lett, 21 (16): (4753-4757). [PMID:21752644] [10.1016/j.bmcl.2011.06.069] |
| 25. McCarthy AR, Pirrie L, Hollick JJ, Ronseaux S, Campbell J, Higgins M, Staples OD, Tran F, Slawin AM, Lain S, Westwood NJ.. (2012) Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.. Bioorg Med Chem, 20 (5): (1779-1793). [PMID:22304848] [10.1016/j.bmc.2012.01.001] |
| 26. Choi SH, Quinti L, Kazantsev AG, Silverman RB.. (2012) 3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2).. Bioorg Med Chem Lett, 22 (8): (2789-2793). [PMID:22446090] [10.1016/j.bmcl.2012.02.089] |
| 27. Suzuki T, Khan MN, Sawada H, Imai E, Itoh Y, Yamatsuta K, Tokuda N, Takeuchi J, Seko T, Nakagawa H, Miyata N.. (2012) Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.. J Med Chem, 55 (12): (5760-5773). [PMID:22642300] [10.1021/jm3002108] |
| 28. Fridén-Saxin M, Seifert T, Landergren MR, Suuronen T, Lahtela-Kakkonen M, Jarho EM, Luthman K.. (2012) Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.. J Med Chem, 55 (16): (7104-7113). [PMID:22746324] [10.1021/jm3005288] |
| 29. Rotili D, Tarantino D, Carafa V, Paolini C, Schemies J, Jung M, Botta G, Di Maro S, Novellino E, Steinkühler C, De Maria R, Gallinari P, Altucci L, Mai A.. (2012) Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.. J Med Chem, 55 (18): (8193-8197). [PMID:22931526] [10.1021/jm301115r] |
| 30. Rotili D, Tarantino D, Nebbioso A, Paolini C, Huidobro C, Lara E, Mellini P, Lenoci A, Pezzi R, Botta G, Lahtela-Kakkonen M, Poso A, Steinkühler C, Gallinari P, De Maria R, Fraga M, Esteller M, Altucci L, Mai A.. (2012) Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.. J Med Chem, 55 (24): (10937-10947). [PMID:23189967] [10.1021/jm3011614] |
| 31. Amagata T, Xiao J, Chen YP, Holsopple N, Oliver AG, Gokey T, Guliaev AB, Minoura K.. (2012) Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.. J Nat Prod, 75 (12): (2193-2199). [PMID:23167691] [10.1021/np300640g] |
| 32. Salo HS, Laitinen T, Poso A, Jarho E, Lahtela-Kakkonen M.. (2013) Identification of novel SIRT3 inhibitor scaffolds by virtual screening.. Bioorg Med Chem Lett, 23 (10): (2990-2995). [PMID:23562596] [10.1016/j.bmcl.2013.03.033] |
| 33. Mellini P, Kokkola T, Suuronen T, Salo HS, Tolvanen L, Mai A, Lahtela-Kakkonen M, Jarho EM.. (2013) Screen of pseudopeptidic inhibitors of human sirtuins 1-3: two lead compounds with antiproliferative effects in cancer cells.. J Med Chem, 56 (17): (6681-6695). [PMID:23927550] [10.1021/jm400438k] |
| 34. Yoon YK, Ali MA, Wei AC, Choon TS, Osman H, Parang K, Shirazi AN.. (2014) Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.. Bioorg Med Chem, 22 (2): (703-710). [PMID:24387981] [10.1016/j.bmc.2013.12.029] |
| 35. Mahajan SS, Scian M, Sripathy S, Posakony J, Lao U, Loe TK, Leko V, Thalhofer A, Schuler AD, Bedalov A, Simon JA.. (2014) Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors.. J Med Chem, 57 (8): (3283-3294). [PMID:24697269] [10.1021/jm4018064] |
| 36. Khanfar MA, Quinti L, Wang H, Choi SH, Kazantsev AG, Silverman RB.. (2014) Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.. Eur J Med Chem, 76 (414-426). [PMID:24602787] [10.1016/j.ejmech.2014.02.003] |
| 37. Parenti MD, Grozio A, Bauer I, Galeno L, Damonte P, Millo E, Sociali G, Franceschi C, Ballestrero A, Bruzzone S, Del Rio A, Nencioni A.. (2014) Discovery of novel and selective SIRT6 inhibitors.. J Med Chem, 57 (11): (4796-4804). [PMID:24785705] [10.1021/jm500487d] |
| 38. Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS.. (2014) Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.. Eur J Med Chem, 83 (448-454). [PMID:24992072] [10.1016/j.ejmech.2014.06.060] |
| 39. Wu J, Li J, Xu MH, Liu D.. (2014) Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole.. Bioorg Med Chem Lett, 24 (14): (3050-3056). [PMID:24880902] [10.1016/j.bmcl.2014.05.028] |
| 40. Khanfar MA, Quinti L, Wang H, Nobles J, Kazantsev AG, Silverman RB.. (2015) Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 Inhibitors.. ACS Med Chem Lett, 6 (5): (607-611). [PMID:26005542] [10.1021/acsmedchemlett.5b00075] |
| 41. Zang W, Hao Y, Wang Z, Zheng W.. (2015) Novel thiourea-based sirtuin inhibitory warheads.. Bioorg Med Chem Lett, 25 (16): (3319-3324). [PMID:26081291] [10.1016/j.bmcl.2015.05.058] |
| 42. Sociali G, Galeno L, Parenti MD, Grozio A, Bauer I, Passalacqua M, Boero S, Donadini A, Millo E, Bellotti M, Sturla L, Damonte P, Puddu A, Ferroni C, Varchi G, Franceschi C, Ballestrero A, Poggi A, Bruzzone S, Nencioni A, Del Rio A.. (2015) Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.. Eur J Med Chem, 102 (530-539). [PMID:26310895] [10.1016/j.ejmech.2015.08.024] |
| 43. Kumar A, Chauhan S.. (2016) How much successful are the medicinal chemists in modulation of SIRT1: A critical review.. Eur J Med Chem, 119 (45-69). [PMID:27153347] [10.1016/j.ejmech.2016.04.063] |
| 44. Chen D, Zheng W.. (2016) Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring Nε-thioacetyl-lysine.. Bioorg Med Chem Lett, 26 (21): (5234-5239). [PMID:27707605] [10.1016/j.bmcl.2016.09.055] |
| 45. Kumar R, Nigam L, Singh AP, Singh K, Subbarao N, Dey S.. (2017) Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease.. Eur J Med Chem, 127 (909-916). [PMID:27836195] [10.1016/j.ejmech.2016.11.001] |
| 46. Lee HY, Nepali K, Huang FI, Chang CY, Lai MJ, Li YH, Huang HL, Yang CR, Liou JP.. (2018) (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo.. J Med Chem, 61 (3): (905-917). [PMID:29304284] [10.1021/acs.jmedchem.7b01404] |
| 47. Pirat C, Dacquet C, Leclerc V, Hennuyer N, Beucher-Gaudin M, Zanirato G, Géant A, Staels B, Ktorza A, Farce A, Caignard DH, Berthelot P, Lebegue N.. (2017) Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.. Eur J Med Chem, 137 (310-326). [PMID:28609708] [10.1016/j.ejmech.2017.06.006] |
| 48. Yang LL, Wang HL, Zhong L, Yuan C, Liu SY, Yu ZJ, Liu S, Yan YH, Wu C, Wang Y, Wang Z, Yu Y, Chen Q, Li GB.. (2018) X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.. Eur J Med Chem, 155 (806-823). [PMID:29957526] [10.1016/j.ejmech.2018.06.041] |
| 49. Damonte P, Sociali G, Parenti MD, Soncini D, Bauer I, Boero S, Grozio A, Holtey MV, Piacente F, Becherini P, Sanguineti R, Salis A, Damonte G, Cea M, Murone M, Poggi A, Nencioni A, Del Rio A, Bruzzone S.. (2017) SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.. Bioorg Med Chem, 25 (20): (5849-5858). [PMID:28958848] [10.1016/j.bmc.2017.09.023] |
| 50. Atobe M, Yamakawa N, Wada Y, Goto T, Kawanishi M, Ito T, Saito M, Takeda M, Tabata T, Arai H.. (2017) A series of novel indazole derivatives of Sirt 1 activator as osteogenic regulators.. Bioorg Med Chem Lett, 27 (21): (4828-4831). [PMID:28988762] [10.1016/j.bmcl.2017.09.049] |
| 51. Hailu GS, Robaa D, Forgione M, Sippl W, Rotili D, Mai A.. (2017) Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.. J Med Chem, 60 (12): (4780-4804). [PMID:28241112] [10.1021/acs.jmedchem.6b01595] |
| 52. Kim MJ, An HJ, Kim DH, Lee B, Lee HJ, Ullah S, Kim SJ, Jeong HO, Moon KM, Lee EK, Yang J, Akter J, Chun P, Moon HR, Chung HY.. (2018) Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.. Bioorg Med Chem Lett, 28 (4): (684-688). [PMID:29402742] [10.1016/j.bmcl.2018.01.021] |
| 53. Monaldi D, Rotili D, Lancelot J, Marek M, Wössner N, Lucidi A, Tomaselli D, Ramos-Morales E, Romier C, Pierce RJ, Mai A, Jung M.. (2019) Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma mansoni (SmSirt2).. J Med Chem, 62 (19): (8733-8759). [PMID:31496251] [10.1021/acs.jmedchem.9b00638] |
| 54. Bouchet S, Linot C, Ruzic D, Agbaba D, Fouchaq B, Roche J, Nikolic K, Blanquart C, Bertrand P.. (2019) Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.. ACS Med Chem Lett, 10 (6): (863-868). [PMID:31223439] [10.1021/acsmedchemlett.8b00440] |
| 55. Valente S, Mellini P, Spallotta F, Carafa V, Nebbioso A, Polletta L, Carnevale I, Saladini S, Trisciuoglio D, Gabellini C, Tardugno M, Zwergel C, Cencioni C, Atlante S, Moniot S, Steegborn C, Budriesi R, Tafani M, Del Bufalo D, Altucci L, Gaetano C, Mai A.. (2016) 1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells.. J Med Chem, 59 (4): (1471-1491). [PMID:26689352] [10.1021/acs.jmedchem.5b01117] |
| 56. Gromek SM, deMayo JA, Maxwell AT, West AM, Pavlik CM, Zhao Z, Li J, Wiemer AJ, Zweifach A, Balunas MJ.. (2016) Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.. Bioorg Med Chem, 24 (21): (5183-5196). [PMID:27614919] [10.1016/j.bmc.2016.08.040] |
| 57. Farooqi AS, Hong JY, Cao J, Lu X, Price IR, Zhao Q, Kosciuk T, Yang M, Bai JJ, Lin H.. (2019) Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.. J Med Chem, 62 (8): (4131-4141). [PMID:30986062] [10.1021/acs.jmedchem.9b00191] |
| 58. Seifert T, Malo M, Kokkola T, Stéen EJL, Meinander K, Wallén EAA, Jarho EM, Luthman K.. (2020) A scaffold replacement approach towards new sirtuin 2 inhibitors.. Bioorg Med Chem, 28 (2): (115231-115231). [PMID:31848116] [10.1016/j.bmc.2019.115231] |
| 59. Sun W, Chen X, Huang S, Li W, Tian C, Yang S, Li L.. (2020) Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.. Bioorg Med Chem Lett, 30 (16): (127215-127215). [PMID:32631504] [10.1016/j.bmcl.2020.127215] |
| 60. Chen X, Sun W, Huang S, Zhang H, Lin G, Li H, Qiao J, Li L, Yang S.. (2020) Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.. J Med Chem, 63 (18): (10474-10495). [PMID:32787077] [10.1021/acs.jmedchem.0c01183] |
| 61. Wang XX,Wan RZ,Liu ZP. (2018) Recent advances in the discovery of potent and selective HDAC6 inhibitors.. Eur J Med Chem, 143 (1406-1418). [PMID:29133060] [10.1016/j.ejmech.2017.10.040] |
| 62. Yang LL,Wang HL,Yan YH,Liu S,Yu ZJ,Huang MY,Luo Y,Zheng X,Yu Y,Li GB. (2020) Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.. Eur J Med Chem, 192 (112201-112201). [PMID:32163813] [10.1016/j.ejmech.2020.112201] |
| 63. Yagci S,Gozelle M,Kaya SG,Ozkan Y,Aksel AB,Bakar-Ates F,Dundar Y,Eren G. (2021) Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.. Bioorg Med Chem, 30 (115961-115961). [PMID:33360574] [10.1016/j.bmc.2020.115961] |
| 64. and Frye, R A RA.. (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.. Biochemical and biophysical research communications, (24): [PMID:10381378] |
| 65. Vaziri, H H and 7 more authors.. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.. Cell, (19): [PMID:11672523] |
| 66. Langley, Emma E and 7 more authors.. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.. The EMBO journal, (15): [PMID:12006491] |
| 67. Bitterman, Kevin J KJ, Anderson, Rozalyn M RM, Cohen, Haim Y HY, Latorre-Esteves, Magda M and Sinclair, David A DA.. (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.. The Journal of biological chemistry, (22): [PMID:12297502] |
| 68. Takata, Takehiko T and Ishikawa, Fuyuki F.. (2003) Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression.. Biochemical and biophysical research communications, (31): [PMID:12535671] |
| 69. Howitz, Konrad T KT and 11 more authors.. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.. Nature, (11): [PMID:12939617] |
| 70. Brunet, Anne A and 16 more authors.. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.. Science (New York, N.Y.), (26): [PMID:14976264] |
| 71. Motta, Maria Carla MC and 8 more authors.. (2004) Mammalian SIRT1 represses forkhead transcription factors.. Cell, (20): [PMID:14980222] |
| 72. van der Horst, Armando A and 5 more authors.. (2004) FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1).. The Journal of biological chemistry, (9): [PMID:15126506] |
| 73. Deloukas, P P and 135 more authors.. (2004) The DNA sequence and comparative analysis of human chromosome 10.. Nature, (27): [PMID:15164054] |
| 74. Cohen, Haim Y HY and 9 more authors.. (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.. Science (New York, N.Y.), (16): [PMID:15205477] |
| 75. Vaquero, Alejandro A and 5 more authors.. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.. Molecular cell, (8): [PMID:15469825] |
| 76. Kuzmichev, Andrei A and 10 more authors.. (2005) Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.. Proceedings of the National Academy of Sciences of the United States of America, (8): [PMID:15684044] |
| 77. Yang, Yonghua Y, Hou, Huayan H, Haller, Edward M EM, Nicosia, Santo V SV and Bai, Wenlong W.. (2005) Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.. The EMBO journal, (9): [PMID:15692560] |
| 78. Pagans, Sara S and 13 more authors.. (2005) SIRT1 regulates HIV transcription via Tat deacetylation.. PLoS biology, [PMID:15719057] |
| 79. Michishita, Eriko E, Park, Jean Y JY, Burneskis, Jenna M JM, Barrett, J Carl JC and Horikawa, Izumi I.. (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.. Molecular biology of the cell, [PMID:16079181] |
| 80. Zhao, Xuan X, Sternsdorf, Thomas T, Bolger, Timothy A TA, Evans, Ronald M RM and Yao, Tso-Pang TP.. (2005) Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.. Molecular and cellular biology, [PMID:16166628] |
| 81. Heltweg, Birgit B and 10 more authors.. (2006) Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.. Cancer research, (15): [PMID:16618762] |
| 82. Wang, Chuangui C and 10 more authors.. (2006) Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.. Nature cell biology, [PMID:16892051] |
| 83. Beausoleil, Sean A SA, Villén, Judit J, Gerber, Scott A SA, Rush, John J and Gygi, Steven P SP.. (2006) A probability-based approach for high-throughput protein phosphorylation analysis and site localization.. Nature biotechnology, [PMID:16964243] |
| 84. Dai, Jin Ming JM, Wang, Zhi Yan ZY, Sun, Dao Chun DC, Lin, Ru Xian RX and Wang, Sheng Qi SQ.. (2007) SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity.. Journal of cellular physiology, [PMID:16998810] |
| 85. Stankovic-Valentin, Nicolas N and 7 more authors.. (2007) An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.. Molecular and cellular biology, [PMID:17283066] |
| 86. Pedersen, Thomas A TA and 7 more authors.. (2007) Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo.. The EMBO journal, (21): [PMID:17290224] |
| 87. Jeong, Jaemin J and 8 more authors.. (2007) SIRT1 promotes DNA repair activity and deacetylation of Ku70.. Experimental & molecular medicine, (28): [PMID:17334224] |
| 88. Dai, Yan Y and 5 more authors.. (2007) Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor.. Molecular endocrinology (Baltimore, Md.), [PMID:17505061] |
| 89. Yuan, Zhigang Z, Zhang, Xiaohong X, Sengupta, Nilanjan N, Lane, William S WS and Seto, Edward E.. (2007) SIRT1 regulates the function of the Nijmegen breakage syndrome protein.. Molecular cell, (6): [PMID:17612497] |
| 90. Wong, Sharon S and Weber, Jason D JD.. (2007) Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1.. The Biochemical journal, (1): [PMID:17620057] |
| 91. Ghosh, Hiyaa S HS, Spencer, James V JV, Ng, Bobby B, McBurney, Michael W MW and Robbins, Paul D PD.. (2007) Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription.. The Biochemical journal, (15): [PMID:17680780] |
| 92. Li, Xiaoling X and 5 more authors.. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR.. Molecular cell, (12): [PMID:17936707] |
| 93. Kim, Eun-Joo EJ, Kho, Jeong-Hoon JH, Kang, Moo-Rim MR and Um, Soo-Jong SJ.. (2007) Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.. Molecular cell, (26): [PMID:17964266] |
| 94. Vaquero, Alejandro A and 5 more authors.. (2007) SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.. Nature, (15): [PMID:18004385] |
| 95. Li, Kai K and 9 more authors.. (2008) Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation.. The Journal of biological chemistry, (21): [PMID:18203716] |
| 96. Kim, Ja-Eun JE, Chen, Junjie J and Lou, Zhenkun Z.. (2008) DBC1 is a negative regulator of SIRT1.. Nature, (31): [PMID:18235501] |
| 97. Zhao, Wenhui W and 5 more authors.. (2008) Negative regulation of the deacetylase SIRT1 by DBC1.. Nature, (31): [PMID:18235502] |
| 98. Kwon, Hye-Sook HS and 9 more authors.. (2008) Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation.. Cell host & microbe, (13): [PMID:18329615] |
| 99. Murayama, Akiko A and 13 more authors.. (2008) Epigenetic control of rDNA loci in response to intracellular energy status.. Cell, (16): [PMID:18485871] |
| 100. Asher, Gad G and 8 more authors.. (2008) SIRT1 regulates circadian clock gene expression through PER2 deacetylation.. Cell, (25): [PMID:18662546] |
| 101. Lan, Fan F, Cacicedo, Jose M JM, Ruderman, Neil N and Ido, Yasuo Y.. (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation.. The Journal of biological chemistry, (10): [PMID:18687677] |
| 102. Ford, Jack J, Ahmed, Shafiq S, Allison, Simon S, Jiang, Ming M and Milner, Jo J.. (2008) JNK2-dependent regulation of SIRT1 protein stability.. Cell cycle (Georgetown, Tex.), [PMID:18838864] |
| 103. Sasaki, Tsutomu T and 7 more authors.. (2008) Phosphorylation regulates SIRT1 function.. PloS one, [PMID:19107194] |
| 104. Pediconi, Natalia N and 8 more authors.. (2009) hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage.. Molecular and cellular biology, [PMID:19188449] |
| 105. Du, Jintang J, Jiang, Hong H and Lin, Hening H.. (2009) Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.. Biochemistry, (7): [PMID:19220062] |
| 106. Zschoernig, Barbara B and Mahlknecht, Ulrich U.. (2009) Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2.. Biochemical and biophysical research communications, (10): [PMID:19236849] |
| 107. Purushotham, Aparna A and 5 more authors.. (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.. Cell metabolism, [PMID:19356714] |
| 108. Yuan, Jian J, Minter-Dykhouse, Katherine K and Lou, Zhenkun Z.. (2009) A c-Myc-SIRT1 feedback loop regulates cell growth and transformation.. The Journal of cell biology, (20): [PMID:19364925] |
| 109. Xie, Yuan-Bin YB and 8 more authors.. (2009) Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation.. The Journal of biological chemistry, (16): [PMID:19690166] |
| 110. Mayya, Viveka V and 7 more authors.. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.. Science signaling, (18): [PMID:19690332] |
| 111. Yamamori, Tohru T and 8 more authors.. (2010) SIRT1 deacetylates APE1 and regulates cellular base excision repair.. Nucleic acids research, [PMID:19934257] |
| 112. Nasrin, Nargis N and 6 more authors.. (2009) JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.. PloS one, (22): [PMID:20027304] |
| 113. Uhl, Miriam M and 5 more authors.. (2010) Role of SIRT1 in homologous recombination.. DNA repair, (4): [PMID:20097625] |
| 114. Wang, Jiadong J and Chen, Junjie J.. (2010) SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60.. The Journal of biological chemistry, (9): [PMID:20100829] |
| 115. Guo, Xiumei X, Williams, Jason G JG, Schug, Thaddeus T TT and Li, Xiaoling X.. (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.. The Journal of biological chemistry, (23): [PMID:20167603] |
| 116. Ghosh, Hiyaa Singhee HS, McBurney, Michael M and Robbins, Paul D PD.. (2010) SIRT1 negatively regulates the mammalian target of rapamycin.. PloS one, (15): [PMID:20169165] |
| 117. Zu, Yi Y and 7 more authors.. (2010) SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.. Circulation research, (30): [PMID:20203304] |
| 118. Chanda, Dipanjan D, Xie, Yuan-Bin YB and Choi, Hueng-Sik HS.. (2010) Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation.. Nucleic acids research, [PMID:20375098] |
| 119. Lim, Ji-Hong JH and 5 more authors.. (2010) Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.. Molecular cell, (25): [PMID:20620956] |
| 120. Fan, Wei W and Luo, Jianyuan J.. (2010) SIRT1 regulates UV-induced DNA repair through deacetylating XPA.. Molecular cell, (30): [PMID:20670893] |
| 121. Ponugoti, Bhaskar B and 9 more authors.. (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.. The Journal of biological chemistry, (29): [PMID:20817729] |
| 122. Wang, Feng-Ming FM, Chen, Yi-Jiun YJ and Ouyang, Hong-Jiao HJ.. (2011) Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation.. The Biochemical journal, (1): [PMID:20955178] |
| 123. Lynch, Cian J and 8 more authors.. (2010) SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.. PloS one, (21): [PMID:20975832] |
| 124. Ming, Mei M and 6 more authors.. (2010) Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C.. Proceedings of the National Academy of Sciences of the United States of America, (28): [PMID:21149730] |
| 125. Yuan, Fang F and 10 more authors.. (2011) MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation.. The Journal of biological chemistry, (4): [PMID:21212262] |
| 126. Liu, Xiangyu X and 9 more authors.. (2011) Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1).. Proceedings of the National Academy of Sciences of the United States of America, (1): [PMID:21245319] |
| 127. Dvir-Ginzberg, Mona M and 5 more authors.. (2011) Tumor necrosis factor α-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes.. Arthritis and rheumatism, [PMID:21305533] |
| 128. Rigbolt, Kristoffer T G KT and 9 more authors.. (2011) System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.. Science signaling, (15): [PMID:21406692] |
| 129. Back, Jung Ho JH and 6 more authors.. (2011) Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1.. The Journal of biological chemistry, (27): [PMID:21471201] |
| 130. Bosch-Presegué, Laia L and 7 more authors.. (2011) Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection.. Molecular cell, (22): [PMID:21504832] |
| 131. Pradhan, Anjan Kumar AK, Kuila, Nivedita N, Singh, Sneha S and Chakraborty, Soumen S.. () EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1.. Biochimica et biophysica acta, [PMID:21555002] |
| 132. Marshall, Glenn M GM and 19 more authors.. (2011) SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.. PLoS genetics, [PMID:21698133] |
| 133. Hirschey, Matthew D MD, Shimazu, Tadahiro T, Capra, John A JA, Pollard, Katherine S KS and Verdin, Eric E.. (2011) SIRT1 and SIRT3 deacetylate homologous substrates: AceCS1,2 and HMGCS1,2.. Aging, [PMID:21701047] |
| 134. Sundaresan, Nagalingam R NR and 9 more authors.. (2011) The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.. Science signaling, (19): [PMID:21775285] |
| 135. Mao, Beibei B and 7 more authors.. (2011) Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.. The international journal of biochemistry & cell biology, [PMID:21807113] |
| 136. Wang, F F and 5 more authors.. (2012) Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.. Oncogene, (22): [PMID:21841822] |
| 137. Wu, Xiaoyan X and 17 more authors.. (2011) SIRT1 links CIITA deacetylation to MHC II activation.. Nucleic acids research, [PMID:21890893] |
| 138. Rizki, Gizem G and 7 more authors.. (2011) The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO.. PLoS genetics, [PMID:21909281] |
| 139. Peng, Lirong L and 9 more authors.. (2011) SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities.. Molecular and cellular biology, [PMID:21947282] |
| 140. Oppenheimer, Hanna H and 8 more authors.. (2012) 75-kd sirtuin 1 blocks tumor necrosis factor α-mediated apoptosis in human osteoarthritic chondrocytes.. Arthritis and rheumatism, [PMID:21987377] |
| 141. Bienvenut, Willy V WV and 6 more authors.. (2012) Comparative large scale characterization of plant versus mammal proteins reveals similar and idiosyncratic N-α-acetylation features.. Molecular & cellular proteomics : MCP, [PMID:22223895] |
| 142. Miki, Takao T and 8 more authors.. (2012) PML regulates PER2 nuclear localization and circadian function.. The EMBO journal, (21): [PMID:22274616] |
| 143. Van Damme, Petra P and 15 more authors.. (2012) N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.. Proceedings of the National Academy of Sciences of the United States of America, (31): [PMID:22814378] |
| 144. Dominy, John E JE and 15 more authors.. (2012) The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis.. Molecular cell, (28): [PMID:23142079] |
| 145. Kim, Wootae W and Kim, Ja-Eun JE.. (2013) Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.. Cancer letters, (10): [PMID:23352644] |
| 146. Hubbard, Basil P and 29 more authors.. (2013) Evidence for a common mechanism of SIRT1 regulation by allosteric activators.. Science (New York, N.Y.), (8): [PMID:23471411] |
| 147. Lakshminarasimhan, Mahadevan; Rauh, David; Schutkowski, Mike and Steegborn, Clemens.. (2013) Sirt1 activation by resveratrol is substrate sequence-selective.. Aging, [PMID:23524286] |
| 148. Laurent, Gaëlle G and 10 more authors.. (2013) SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.. Molecular and cellular biology, [PMID:24043310] |
| 149. Hoffmann, Gesine G, Breitenbücher, Frank F, Schuler, Martin M and Ehrenhofer-Murray, Ann E AE.. (2014) A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.. The Journal of biological chemistry, (21): [PMID:24379401] |
| 150. Nin, Veronica V, Chini, Claudia C S CC, Escande, Carlos C, Capellini, Verena V and Chini, Eduardo N EN.. (2014) Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis.. The Journal of biological chemistry, (28): [PMID:24415752] |
| 151. Pangon, Laurent L and 8 more authors.. (2015) MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.. International journal of cancer, (1): [PMID:24824780] |
| 152. Magni, Martina M and 7 more authors.. (2014) Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.. Nucleic acids research, (1): [PMID:25361978] |
| 153. Park, Jong Ho JH and 9 more authors.. (2014) Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.. Nature communications, (18): [PMID:25406032] |
| 154. Sakurabashi, Ayako A and 12 more authors.. (2015) CCAR2 negatively regulates nuclear receptor LXRα by competing with SIRT1 deacetylase.. The Journal of steroid biochemistry and molecular biology, [PMID:25661920] |
| 155. Olson, Heather E HE and 57 more authors.. (2018) A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.. American journal of human genetics, (3): [PMID:29656858] |
| 156. Li, Terytty Yang TY and 16 more authors.. (2018) Tip60-mediated lipin 1 acetylation and ER translocation determine triacylglycerol synthesis rate.. Nature communications, (15): [PMID:29765047] |
| 157. Latorre-Muro, Pedro P and 9 more authors.. (2018) Dynamic Acetylation of Phosphoenolpyruvate Carboxykinase Toggles Enzyme Activity between Gluconeogenic and Anaplerotic Reactions.. Molecular cell, (6): [PMID:30193097] |
| 158. Dalal, Sayli; Deshmukh, Prashant; Unni, Sruthi; Padavattan, Sivaraman and Padmanabhan, Balasundaram.. (2019) Biochemical insight into pseudouridine synthase 7 (PUS7) as a novel interactor of sirtuin, SIRT1.. Biochemical and biophysical research communications, (20): [PMID:31451225] |
| 159. Wang, Jiajia and 11 more authors.. (2020) Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation.. Nature communications, (7): [PMID:32034146] |
ZJ24F0708453